Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease | Zendy

Michael Boehme | Zendy; F. Kaehne | Zendy; Ana I. Kuehne | Zendy; Wanja M. Bernhardt | Zendy; M. Schröder | Zendy; Wolfgang Pommer | Zendy; Christina Weide Fischer | Zendy; Christoph R. Becker | Zendy; Christian Müller | Zendy; Ralf Schindler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease

Author(s) -

Michael Boehme,

F. Kaehne,

Ana I. Kuehne,

Wanja M. Bernhardt,

M. Schröder,

Wolfgang Pommer,

Christina Weide Fischer,

Christoph R. Becker,

Christian Müller,

Ralf Schindler

Publication year - 2007

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfl747

Subject(s) - medicine , ptx3 , dialysis , hemodialysis , kidney disease , erythropoietin , renal replacement therapy , gastroenterology , peritoneal dialysis , c reactive protein , population , coronary artery disease , serum amyloid p component , inflammation , environmental health

Pentraxins are mediators of inflammation as well as markers of the acute-phase reaction. While elevation of C-reactive protein (CRP) in patients with renal failure and its association with cardiovascular disease is well described, there are no data on pentraxin 3 (PTX3) in this population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research